|
MYL12A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.440100E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.575800E-03 |
| Normal-vs-Stage2 |
1.964220E-03 |
| Normal-vs-Stage3 |
1.796660E-04 |
| Normal-vs-Stage4 |
5.390100E-04 |
| Stage1-vs-Stage2 |
3.484800E-01 |
| Stage1-vs-Stage3 |
8.130000E-02 |
| Stage1-vs-Stage4 |
2.068200E-01 |
| Stage2-vs-Stage3 |
7.405400E-01 |
| Stage2-vs-Stage4 |
9.083800E-01 |
| Stage3-vs-Stage4 |
8.078000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.803800E-04 |
| Normal-vs-AfricanAmerican |
6.792700E-04 |
| Normal-vs-Asian |
1.576380E-01 |
| Caucasian-vs-AfricanAmerican |
2.887400E-01 |
| Caucasian-vs-Asian |
6.926000E-01 |
| AfricanAmerican-vs-Asian |
9.831400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.205400E-04 |
| Normal-vs-Female |
1.063930E-03 |
| Male-vs-Female |
9.413000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.413840E-01 |
| Normal-vs-Age(41-60Yrs) |
3.601800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.839860E-04 |
| Normal-vs-Age(81-100Yrs) |
5.637400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.904200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.443600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.431170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.139600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.017390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.580800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.627000E-01 |
| Normal-vs-Grade 2 |
1.804230E-02 |
| Normal-vs-Grade 3 |
4.22900000000004E-05 |
| Normal-vs-Grade 4 |
1.399780E-04 |
| Grade 1-vs-Grade 2 |
3.676400E-01 |
| Grade 1-vs-Grade 3 |
2.141700E-02 |
| Grade 1-vs-Grade 4 |
4.225600E-02 |
| Grade 2-vs-Grade 3 |
4.996600E-04 |
| Grade 2-vs-Grade 4 |
7.275400E-03 |
| Grade 3-vs-Grade 4 |
7.179600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.418220E-02 |
| Normal-vs-ccB subtype |
1.423230E-04 |
| ccA subtype-vs-ccB subtype |
6.682600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.426600E-04 |
| Normal-vs-N1 |
2.029400E-01 |
| N0-vs-N1 |
4.958200E-01 |
|
|
